“Phase 1b randomized study of antidote-controlled modulation of IXa activity in patients with stable coronary-artery disease”
Chan MY, Cohen MG, Dyke CK et al.
Circulation 2008;117:2865-2874
To be presented by Ben Williams, M.D.
“Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation”
To be presented by Vien Le, M.D.
To be presented by Vijay Iyer, M.D.
“Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials”
Abdel-Latif A, Bolli R, Zuba-Surma EK et al.
American Heart Journal 2008;156:216-226
“Clopidogrel pre-treatment in stable angina: For all patients > 6 hours before elective coronary angiography, or only for angiographically-selected patients a few minutes before PCI? A randomized multicentre trial (PRAGUE-8)”
Widimsky P, Motovska Z, Simek S et al. (for the PRAGUE-8 investigators)
European Heart Journal 2008;29:1495-1503
“Effect of cyclosporine on reperfusion injury in acute myocardial infarction”
Piot C, Croisille P, Staat P et al.
“(A) randomized controlled trial of coronary-artery bypass surgery vs. percutaneous coronary intervention in patients with multivessel coronary-artery disease: Six-year follow-up from the Stent or Surgery trial (SoS)”
Booth J, Clayton T, Pepper J et al.
Circulation 2008;118:381-388
“Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual-antiplatelet therapy: Involvement of factors other than platelet aggregability in Virchow's triad”
Yano Y, Ohmori T, Hoshide S et al.
Europrean Heart Journal 2008;29:1729-1738
“Vasopressin and epinephrine vs. einephrine alone in cardiopulmonary resuscitation”
Gueugniaud PY, David JS, Chanzy E et al.
“iCoapsys mitral-valve repair system: Percutaneous implantation in an animal model”
Pedersen WR, Block P, Leon M et al.
Catheterization and Cardiovascular Interventions 2008;72:125-131
“Functional recovery after acute myocardial infarction: Comparison between angiography, electrocardiography, and cardiovascular magnetic-resonance measures of microvascular injury”
Nijveldt R, Beek AM, Hirsch A et al.
“Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The randomized Leipzig immediate percutaneous coronary-intervention abciximab IV vs. IC in ST-elevation myocardial infarction trial”
Thiele H, Schindler K, Friedenberger J et al.
Circulation 2008;118:49-57
“Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow-velocity measurements in patients with acute anterior-wall myocardial infarction”
Hirsch A, Nijveldt R, Haeck JD et al.
“Early invasive vs. conservative treatment strategies in women and men with unstable angina and non-ST-segment-elevation myocardial infarction: A meta-analysis”
O'Donoghue M, Boden WE, Braunwald E et al.
“The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention”
Gurm HS, Smith DE, Collins JS et al.
“A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single- and multi-vessel coronary disease: primary results of the COSTAR (CObalt chromium STent with Antiproliferative for Restenosis) II study”
Krucoff MW, Kereiakes DJ, Petersen JL et al.
“A citywide protocol for primary PCI in ST-segment-elevation myocardial infarction”
Lemay MR, So DY, Dionne R et al.
|
Return to: : Medical School : Academic Health Center : myU : U of M Home
